| Unraveling the functional role of DNA demethylation at specific promoters by targeted steric blockage of DNA methyltransferase with CRISPR/dCas9 DM Sapozhnikov, M Szyf Nature Communications 12 (1), 5711, 2021 | 49 | 2021 |
| DNA methylation controls unmethylated transcription start sites in the genome in trans D Cheishvili, S Christiansen, R Stochinsky, AS Pepin, DM Sapozhnikov, ... Epigenomics 9 (5), 611-633, 2017 | 19 | 2017 |
| Transcriptome sequencing reveals candidate NF-κB target genes involved in repeated cocaine administration Y Wang, H Teng, DM Sapozhnikov, Q Du, M Zhao International Journal of Neuropsychopharmacology 21 (7), 697-704, 2018 | 8 | 2018 |
| Adult neural stem cell multipotency and differentiation are directed by the methyl-CpG-binding protein MBD1 E Lax, DM Sapozhnikov Journal of Neuroscience 37 (16), 4228-4230, 2017 | 7 | 2017 |
| Enzyme-free targeted DNA demethylation using CRISPR–dCas9-based steric hindrance to identify DNA methylation marks causal to altered gene expression DM Sapozhnikov, M Szyf Nature Protocols 17 (12), 2840-2881, 2022 | 6 | 2022 |
| Reduction of DNMT3a and RORA in the nucleus accumbens plays a causal role in post-traumatic stress disorder-like behavior: reversal by combinatorial … G Warhaftig, N Zifman, CM Sokolik, R Massart, O Gabay, D Sapozhnikov, ... Molecular Psychiatry 26 (12), 7481-7497, 2021 | 6 | 2021 |
| Methyl-CpG binding domain 2 (Mbd2) is an epigenetic regulator of autism-risk genes and cognition E Lax, S Do Carmo, Y Enuka, DM Sapozhnikov, LA Welikovitch, ... Translational Psychiatry 13 (1), 259, 2023 | 4 | 2023 |
| The promise of mindfulness-based interventions as therapies to prevent cognitive decline D Sapozhnikov McGill Science Undergraduate Research Journal 10 (1), 49-54, 2015 | 4 | 2015 |
| Increasing specificity of targeted DNA methylation editing by non-enzymatic CRISPR/dCas9-based steric hindrance DM Sapozhnikov, M Szyf Biomedicines 11 (5), 1238, 2023 | 3 | 2023 |
| Dnmt3a2 in the nucleus accumbens shell mediates cue-induced cocaine-seeking behavior E Lax, DM Sapozhnikov The Journal of Neuroscience 39 (14), 2574, 2019 | 3 | 2019 |
| The PROTECTOR strategy employs dCas orthologs to sterically shield off-target sites from CRISPR/Cas activity DM Sapozhnikov, M Szyf Scientific Reports 13 (1), 2280, 2023 | 2 | 2023 |
| Uncommon side effects of common drugs in patients with familial dysautonomia L Perl, D Hakimian, C Maayan, D Rekhtman, E Fried, M Salmon‐Divon, ... Pharmacoepidemiology and Drug Safety 31 (2), 128-140, 2022 | 1 | 2022 |
| Genetic confounds of transgenerational epigenetic inheritance in mice DM Sapozhnikov, M Szyf Epigenetics 19 (1), 2318519, 2024 | | 2024 |
| Deconvoluting the functional role of DNA methylation in trauma; Implications for epigenetic therapy and prospects of targeted “epigenetic therapy” G Warhaftig, D Sapozhnikov, G Yadid, M Szyf Sex, Gender, and Epigenetics, 81-92, 2023 | | 2023 |
| Genetic Polymorphisms in the ESR1 and VDR Genes Do Not Correlate With Osteoporosis in Patients With Familial Dysautonomia D Cheishvili, C Maayan, DM Sapozhnikov, E Lax, R Dresner-Pollak Journal of Clinical Densitometry 21 (2), 205-212, 2018 | | 2018 |
Moshe SzyfProfessor of Pharmacology McGill UniversityVerified email at mcgill.ca
